Long COVID risk reduced by common diabetes drug
Metformin, a drug commonly used to treat diabetes, can reduce the risk of developing long COVID by over 40%, according to a study published in
Metformin, a drug commonly used to treat diabetes, can reduce the risk of developing long COVID by over 40%, according to a study published in
A novel treatment for healing diabetic foot ulcers (DFUs) could be on the horizon for people with diabetes in the US. Diabetic foot ulcers are
Nemaura Medical has announced interim results from its collaboration with the UK’s National Health Service on its Metabolic Health & Weight Loss Program. Known as
From April 2023 Medicare has increased access to continuous glucose monitoring (CGM) in the US to people on insulin therapies who are also having hypoglycemia.
Medtronic plans to integrate its new insulin dosing algorithm, which is used in the 780G pump, with EOFlow’s pump and is offering to buy all
The July-September 2023 issue of JDRF’s Type 1 Discovery magazine is now available online. In this issue, Professor Partha Kar speaks about his work and
Depression can play a direct role in the development of Type 2 diabetes, according to new research. A Diabetes UK-funded study, published in Diabetes Care,
Challenging conventional wisdom, new research suggests that hitting the ‘Snooze’ button does not lead to cognitive impairment on waking and may actually provide cognitive benefits.
While continuous glucose monitors (CGMs) can provide real-time data and alerts to help people with diabetes make informed decisions about their health, it has been
Neatly, in advance of this year’s World Diabetes Day – held 14 November 2023 – the UK’s National Institute for Health and Care Excellence (NICE)